EXPLORINEER
en

KR — 전자신문

Hancom Life Care Signs 18.9 Billion Won K5 Gas Mask Supply Deal with DAPA

Policy1 min read

Hanwha... no, Hancom LifeCare, a Hancom Group company, signed a 18.9 billion won deal with South Korea's Defense Acquisition Program Administration (DAPA) to supply K5 gas masks. The company will deliver about 301,450 units by 2027.

What happened

Hancom LifeCare said it signed a 10th supply contract for K5 gas masks with DAPA. The deal is worth 18.9 billion won. The company will deliver 80,744 gas masks and 220,706 filter canisters, for a total of 301,450 items, by 2027. A gas mask is a face mask that protects people from chemical, biological, and nuclear threats.

Key numbers

  • Contract value: 18.9 billion won
  • Gas masks: 80,744 units
  • Filter canisters: 220,706 units
  • Total delivery: 301,450 items by 2027
  • Government plan: about 290 billion won to replace about 1.07 million K5 masks by 2030

Background

The K5 mask is a newer chemical protection system that improves on the older K1 mask. It has a one-piece front lens that gives a wide view, which helps soldiers shoot during combat. It uses light composite materials to feel more comfortable. Its filter canisters mount on both the left and right sides, which lowers breathing resistance. Hancom LifeCare began mass production in 2015 and has won work on each round since then. It started developing the K5 in 2010 and finished in 2014.

Why it matters

This deal shows that Hancom LifeCare can make defense products, not just fire and public safety gear. The company is trying to grow into a major defense business. Steady orders from the military could give it a stable source of income for years.

What to watch

  • Whether more K5 mask orders follow as the army replaces old masks through 2030
  • How fast Hancom LifeCare delivers the 301,450 items by 2027
  • Growth of its newer defense products, such as unmanned ground vehicles (UGVs)

Same story, different eyes

Ad

Add 150 words. Learn 10 a day.

Dicter word books send only the words you learn to your review notes.

PolicyArs Technica

GLP-1 drugs could have a surprisingly large environmental payoff

New research suggests that widespread use of GLP-1 weight-loss medicines such as Ozempic and Wegovy could reshape the global food system. A simulation estimated that reduced calorie intake could prevent up to 6.6 million deaths a year by 2050 and free up to 32 million hectares of farmland, and up to 46 million hectares when combined with healthier diets. The researchers note that cheaper food could partly offset the benefits for non-users, so the findings should not be read simply as an argument for more medication.

Policyheise online

Bundesrat Calls for Stricter Rules on Smart Glasses and Deepfakes

Germany's Bundesrat, the upper house of parliament, adopted a statement on the government's draft law strengthening civil and criminal protection against digital violence, saying it welcomes the goal but finds key parts too narrow or too mildly sanctioned. It asks that the TDDDG privacy law be extended to recording-capable devices such as smart glasses, while the Federal Network Agency currently sees no grounds to ban models like the Ray-Ban Meta Glasses. The Bundesrat also wants higher maximum prison terms for distributing sexualized deepfakes and revised wording on deception and fake-image offenses.

PolicyZDNet Korea

Trump Warns US Big Tech of "Tax Bombs" for Overseas Data Centers

US President Donald Trump said American companies would face heavy taxes for building AI data centers abroad, and that he would not allow them to build data centers outside the United States. He did not disclose specific tax rates, the scope of application, or a timeline, and said he had not yet informed his administration of the plan. The remarks came shortly after his Asia trip, as the US Commerce Department separately moved to require export licenses for advanced chips when overseas data center computing resources are supplied to companies in countries of concern such as China.

PolicyArs Technica

Review: Godzilla Minus Zero joins the list of truly stellar sequels

Critic review says Godzilla Minus Zero, director Takashi Yamazaki's sequel to Godzilla Minus One, ranks among the rare sequels that match or surpass their predecessors. The article notes the film combines human drama, strong special effects, and a giant-monster battle, and it follows Minus One's postwar setting and themes of guilt and redemption.